Specifically, it has been proposed that the upregulation of PPARγ and CD36 in NAFLD might increase hepatic lipid uptake and promote the development of steatosis [3, 17]. This evidence concerns the gene CD36 and metabolic dysfunction-associated steatotic liver disease.